Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 May 19;32(8):E4–E8. doi: 10.1002/clc.20488

Long‐Term Survival and Outcomes After Hospitalization for Acute Myocardial Infarction Complicated by Cardiogenic Shock

Stavros G Drakos 1, Michael J Bonios 1, Maria I Anastasiou‐Nana 2, Eleftheria P Tsagalou 1, John V Terrovitis 1, Elisabet Kaldara 1, George Maroulidis 1, Serafim N Nanas 3, John Kanakakis 2, John N Nanas 3,✉
PMCID: PMC6653738  PMID: 19455673

Abstract

Background

Cardiogenic shock is the leading cause of death during hospitalization for acute myocardial infarction (MI). However, little data exist regarding the long‐term outcomes of patients who survived the acute phase of MI and were discharged from the hospital.

Methods

We retrospectively reviewed the records of 81 consecutive patients referred for management of acute MI and cardiogenic shock to analyze their in‐hospital and long‐term outcomes.

Results

Mean systemic systolic and central venous pressures at presentation were 74 ± 15 and 17 ± 7 mm Hg, respectively. Intra‐aortic balloon counterpulsation (IABC) was implemented in all patients for a mean of 88 ± 83 hours. Thrombolytics were administered in 49% and mechanical ventilation applied in 46% of patients. Primary angioplasty could not be performed in any patient, while 17 patients later underwent myocardial revascularization during hospitalization. There were 37 in‐hospital survivors (45.7%). The 1‐year survival after discharge from the hospital was 87.6% in the overall population, versus 100% among patients who underwent in‐hospital myocardial revascularization, versus 78.9% among nonrevascularized patients (p = 0.079). Over a mean follow‐up of 85 ± 47 mo, survival after discharge from the index hospitalization was 44.9% in the overall population, versus 56.2% among revascularized patients, versus 36.4% among nonrevascularized patients (p = 0.277). Heart failure developed in 51.6% of patients who were discharged from the hospital.

Conclusions

In this single center analysis, the long‐term survival after acute MI complicated by cardiogenic shock was high with nearly 50% of patients surviving free from heart failure. Copyright © 2009 Wiley Periodicals, Inc.

Full Text

The Full Text of this article is available as a PDF (142.3 KB).

References

  • 1. Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO‐I trial experience. The GUSTO‐I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995; 26: 668–674. [DOI] [PubMed] [Google Scholar]
  • 2. Sanborn TA, Feldman T. Management strategies for cardiogenic shock. Curr Opin Cardiol 2004; 19: 608–612. [DOI] [PubMed] [Google Scholar]
  • 3. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock? N Engl J Med 1999; 341: 625–634. [DOI] [PubMed] [Google Scholar]
  • 4. Holmes DR Jr, Califf RM, Van de Werf F, et al. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet 1997; 349: 75–78. [DOI] [PubMed] [Google Scholar]
  • 5.The Trace Study Group. The TRAndolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population. Am J Cardiol 1994; 73: 44C–50C. [DOI] [PubMed] [Google Scholar]
  • 6. Duvernoy CS, Bates ER. Management of cardiogenic shock attributable to acute myocardial infarction in the reperfusion era. J Intensive Care Med 2005; 20: 188–198. [DOI] [PubMed] [Google Scholar]
  • 7. Hochman JS, Sleeper LA, White HD, et al. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock? One‐year survival following early revascularization for cardiogenic shock. JAMA 2001; 285: 190–192. [DOI] [PubMed] [Google Scholar]
  • 8. Jacobs AK, Leopold JA, Bates E, et al. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol 2003; 41: 1273–1279. [DOI] [PubMed] [Google Scholar]
  • 9. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2004; 44: E201–E211. [DOI] [PubMed] [Google Scholar]
  • 10. Moulopoulos SD, Stamatelopoulos SF, Nanas JN, Kontoyannis DA, Nanas SN. Effect of protracted dobutamine infusion on survival of patients in cardiogenic shock treated with intra‐aortic balloon pumping. Chest 1993; 103: 248–252. [DOI] [PubMed] [Google Scholar]
  • 11. Babaev A, Frederick P, Pasta D, et al. NRMI Investigators: Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005; 294: 448–454. [DOI] [PubMed] [Google Scholar]
  • 12. Reynolds HR, Hochman JS. Cardiogenic shock current concepts and improving outcomes. Circulation 2008; 117: 686–697. [DOI] [PubMed] [Google Scholar]
  • 13. Goldberg RJ, Samad NA, Yarzebski J, et al. NRMI Investigators: temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999; 340: 1162–1168. [DOI] [PubMed] [Google Scholar]
  • 14. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction‐etiologies, management and outcome: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000; 36: 1063–1070. [DOI] [PubMed] [Google Scholar]
  • 15. Berger PB, Tuttle RH, Holmes DR Jr, et al. One‐year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization. results from the GUSTO‐I Trial. Circulation 1999; 99: 873–878. [DOI] [PubMed] [Google Scholar]
  • 16. Bengtson JR, Kaplan AJ, Pieper KS, et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol 1992; 20: 1482–1489. [DOI] [PubMed] [Google Scholar]
  • 17. Eltchaninoff H, Simpfendorfer C, Franco I, et al. Early and 1‐year survival rates in acute myocardial infarction complicated by cardiogenic shock: a retrospective study comparing coronary angioplasty with medical treatment. Am Heart J 1995; 130: 459–464. [DOI] [PubMed] [Google Scholar]
  • 18. Antoniucci D, Valenti R, Santoro G, et al. Systematic direct angioplasty and stent‐supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in‐hospital and long‐term survival. J Am Coll Cardiol 1998; 31: 294–300. [DOI] [PubMed] [Google Scholar]
  • 19. Ammann P, Straumann E, Naegeli B, et al. Long‐term results after acute percutaneus transluminal coronary angioplasty in acute myocardial infarction and cardiogenic shock. Int J Cardiol 2002; 82: 127–131. [DOI] [PubMed] [Google Scholar]
  • 20. Hochman JS, Sleeper LA, Webb JG, et al. SHOCK Investigators: early revascularization and long‐term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006; 295: 2511–2515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Holmes DR Jr, Kip KE, Kelsey SF, Detre KM, Rosen AD. Cause of death analysis in the NHLBI PTCA Registry: results and considerations for evaluating long‐term survival after coronary interventions. J Am Coll Cardiol 1997; 30: 881–887. [DOI] [PubMed] [Google Scholar]
  • 22. Alter DA, Naylor CD, Austin PC, Tu JV. Long‐term MI outcomes at hospitals with or without on‐site revascularization. JAMA 2001; 285: 2101–2108. [DOI] [PubMed] [Google Scholar]
  • 23. Sleeper LA, Jacobs AK, LeJemtel T, Webb JG, Hochman JS. A mortality model and severity scoring system for cardiogenic shock complicating acute myocardial infarction [abstract]. Circulation 2000; 102: 38–40. [Google Scholar]
  • 24. Fincke R, Hochman JS, Lowe AM, et al. SHOCK Investigators: Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK Trial Registry. J Am Coll Cardiol 2004; 44: 340–348. [DOI] [PubMed] [Google Scholar]
  • 25. Singh M, White J, Hasdai D, et al. Long‐term outcome and its predictors among patients with ST‐segment elevation myocardial infarction complicated by shock: insights from the GUSTO‐I trial. J Am Coll Cardiol 2007; 50: 1752–1758. [DOI] [PubMed] [Google Scholar]
  • 26. Lim S, Jeong M, Bae E, et al. Predictive factors of major adverse cardiac events in acute myocardial infarction patients complicated by cardiogenic shock undergoing primary percutaneous coronary intervention. Circ J 2005; 69: 154–158. [DOI] [PubMed] [Google Scholar]
  • 27. Brønnum‐Hansen H, Jørgensen T, Davidsen M, et al. Survival and cause of death after myocardial infarction: the Danish MONICA study. J Clin Epidemiol 2001; 54: 1244–1250. [DOI] [PubMed] [Google Scholar]
  • 28. Sleeper LA, Ramanathan K, Picard MH, et al. SHOCK Investigators: Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 2005; 46: 266–273. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES